ICUI - ICU Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
San Clemente,
United States
Type: Equity
ICUI price evolution
ICUI
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $302.65 | $251.42 | $254.22 | |
| Short term investments | $0.5 | |||
| Net receivables | $177.72 | $151.76 | $145.19 | $161.57 |
| Inventory | $692.04 | $682.87 | $693.01 | $709.36 |
| Total current assets | $1258.06 | $1235.99 | $1187.73 | $1221.27 |
| Long term investments | ||||
| Property, plant & equipment | $658.53 | $660.49 | $667.54 | $682.82 |
| Goodwill & intangible assets | $2256.73 | $2296.27 | $2343.03 | |
| Total noncurrent assets | $3050.68 | $3100.67 | $3157.17 | |
| Total investments | $0.5 | |||
| Total assets | $4305.04 | $4286.67 | $4288.4 | $4378.44 |
| Current liabilities | ||||
| Accounts payable | $168.56 | $155.51 | $152.48 | $150.03 |
| Deferred revenue | ||||
| Short long term debt | $51 | $51 | $51 | |
| Total current liabilities | $549.56 | $511.91 | $455.36 | $481.84 |
| Long term debt | $1545.58 | $1554.82 | $1566.3 | $1577.77 |
| Total noncurrent liabilities | $1736.95 | $1765.21 | $1773.19 | |
| Total debt | $1605.82 | $1617.3 | $1628.77 | |
| Total liabilities | $2256.45 | $2248.86 | $2220.57 | $2255.03 |
| Shareholders' equity | ||||
| Retained earnings | $713.99 | $746.97 | $768.38 | $807.85 |
| Other shareholder equity | -$64.07 | -$91.78 | -$69.54 | -$53.08 |
| Total shareholder equity | $2037.81 | $2067.83 | $2123.41 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $254.22 | $208.78 | $552.83 | $396.1 |
| Short term investments | $0.5 | $4.22 | $14.42 | $14.69 |
| Net receivables | $161.57 | $225.26 | $105.89 | $124.09 |
| Inventory | $709.36 | $696.01 | $290.24 | $314.93 |
| Total current assets | $1221.27 | $1235.2 | $1029.81 | $920.78 |
| Long term investments | $0.52 | $4.62 | $12.97 | |
| Property, plant & equipment | $682.82 | $713.58 | $508.21 | $513.2 |
| Goodwill & intangible assets | $2343.03 | $2432.02 | $231.75 | $230.23 |
| Total noncurrent assets | $3157.17 | $3280.45 | $850.93 | $842.91 |
| Total investments | $0.5 | $4.74 | $19.04 | $27.66 |
| Total assets | $4378.44 | $4515.64 | $1880.74 | $1763.69 |
| Current liabilities | ||||
| Accounts payable | $150.03 | $215.9 | $81.13 | $71.86 |
| Deferred revenue | ||||
| Short long term debt | $51 | $29.69 | ||
| Total current liabilities | $481.84 | $494.56 | $200.78 | $195.49 |
| Long term debt | $1577.77 | $1625.53 | $2.07 | $2.4 |
| Total noncurrent liabilities | $1773.19 | $1931.15 | $63.93 | $65.94 |
| Total debt | $1628.77 | $1653.36 | ||
| Total liabilities | $2255.03 | $2425.71 | $264.71 | $261.43 |
| Shareholders' equity | ||||
| Retained earnings | $807.85 | $837.5 | $911.79 | $808.65 |
| Other shareholder equity | -$53.08 | -$121.76 | -$19.27 | -$1.52 |
| Total shareholder equity | $2123.41 | $2089.93 | $1616.03 | $1502.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $596.46 | $566.65 | $587.86 | |
| Cost of revenue | $389.03 | $381.41 | $416.27 | |
| Gross Profit | $207.43 | $185.24 | $171.59 | |
| Operating activities | ||||
| Research & development | $23.39 | $21.84 | $22.41 | |
| Selling, general & administrative | $159.55 | $157.66 | $154.62 | |
| Total operating expenses | $200.07 | $195.6 | $187.76 | |
| Operating income | $7.35 | -$10.36 | -$16.17 | |
| Income from continuing operations | ||||
| EBIT | $4.31 | -$13 | -$12.27 | |
| Income tax expense | $1.87 | $2.7 | -$19.53 | |
| Interest expense | $23.84 | $23.77 | $24.41 | |
| Net income | ||||
| Net income | -$21.41 | -$39.47 | -$17.15 | |
| Income (for common shares) | -$21.41 | -$39.47 | -$17.15 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2259.13 | $2280 | $1316.31 | $1271 |
| Cost of revenue | $1519.25 | $1582.24 | $824.82 | $809.51 |
| Gross Profit | $739.87 | $697.76 | $491.49 | $461.5 |
| Operating activities | ||||
| Research & development | $85.34 | $92.98 | $47.5 | $42.95 |
| Selling, general & administrative | $606.69 | $608.35 | $302.58 | $283.95 |
| Total operating expenses | $733.29 | $772.75 | $368.25 | $354.33 |
| Operating income | $6.58 | -$74.99 | $123.25 | $107.16 |
| Income from continuing operations | ||||
| EBIT | $16.92 | -$48.03 | $124.04 | $99.25 |
| Income tax expense | -$48.64 | -$40.12 | $20.05 | $10.62 |
| Interest expense | $95.22 | $66.38 | $0.86 | $1.75 |
| Net income | ||||
| Net income | -$29.66 | -$74.29 | $103.14 | $86.87 |
| Income (for common shares) | -$29.66 | -$74.29 | $103.14 | $86.87 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$21.41 | -$39.47 | -$17.15 | |
| Operating activities | ||||
| Depreciation | $60.5 | $60.87 | $62.53 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11 | $11.6 | $10.69 | |
| Total cash flows from operations | $81.95 | $45.79 | $91.27 | |
| Investing activities | ||||
| Capital expenditures | -$21.69 | -$18.36 | -$31.95 | |
| Investments | $0.5 | $1.3 | ||
| Total cash flows from investing | -$62.41 | -$21.69 | -$17.86 | -$30.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.92 | $0.15 | ||
| Net borrowings | -$13.02 | -$12.99 | -$7.72 | |
| Total cash flows from financing | -$47.61 | -$10.38 | -$26.84 | -$7.85 |
| Effect of exchange rate | $4.47 | $1.35 | -$3.88 | $4.26 |
| Change in cash and equivalents | $58.29 | $51.23 | -$2.8 | $57.03 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$29.66 | -$74.29 | $103.14 | $86.87 |
| Operating activities | ||||
| Depreciation | $250.68 | $258.8 | $99.29 | $94.85 |
| Business acquisitions & disposals | -$1844.16 | -$14.45 | ||
| Stock-based compensation | $40.56 | $36.02 | $27.34 | $23.95 |
| Total cash flows from operations | $166.2 | -$62.13 | $267.54 | $222.75 |
| Investing activities | ||||
| Capital expenditures | -$92.17 | -$98.34 | -$80.95 | -$94.21 |
| Investments | $4.22 | $33.04 | $4.72 | -$3.92 |
| Total cash flows from investing | -$87.95 | -$1909.47 | -$90.69 | -$98.14 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.02 | $8.79 | $9.37 | $13.19 |
| Net borrowings | -$30.65 | $1639.13 | -$0.61 | -$0.36 |
| Total cash flows from financing | -$35.98 | $1637.03 | -$16.87 | -$0.04 |
| Effect of exchange rate | $3.16 | -$9.48 | -$3.25 | $2.85 |
| Change in cash and equivalents | $45.44 | -$344.04 | $156.73 | $127.43 |
News
Fundamentals
| Market cap | $3.43B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 24.46M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.06 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.29 |
| Quick ratio | 1.03 |